This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 10th-11th, 2025Boston Exhibition & Convention Center, USA

Building Collaborative Alliances to Fast-Track RNA Therapeutics & Vaccines from Discovery to the North American Market

Join key stakeholders to examine new data & case studies, assess the latest technologies, their potential and forge the collaborations needed to bring new discoveries to market

RNA Leaders USA ... The Numbers

450+

Attendees

1:1

Partnering

4

Tracks of Content

Learn From Today's Brightest RNA Minds

The RNA Leaders program features scientific tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum and areas of focus below:

mRNA Vaccine & Therapeutics

  • Delve into pre-clinical and clinical mRNA therapeutics and vaccine advancement for oncology cardiology, respiratory, neurology & rare diseases
  • Progress mRNA 2.0 modalities such as self-amplifying RNAs and self-replicating RNAs

Oligo-Based RNA Therapeutics

  • Progress & assess the development of antisense oligonucleotides & siRNAs into the clinic for rare disease and chronic indications
  • Explore new solutions to oligonucleotide drug delivery challenges

Next-Gen RNA

  • Uncover emerging RNA modalities and applications such as circular RNAs, dark genome, RNA editing, diagnostics, RNA editing and cell therapy
  • Understand novel RNA targets and approaches including small molecule drug discovery, deeper RNA biological MOAs

Delivery & Process Development

  • Discover novel delivery techniques beyond standard LNP and extrahepatic delivery, delivery solutions short RNAs including conjugates and naked formulations and optimising payloads
  • Assess platforms and raw materials to reduce mRNA production at scale and translate regulatory outlines to mRNA therapeutics

The PolymeRAI$E

  • Showcasing early-stage innovative RNA technologies to tackle key challenges such as delivery, cell/tissue specificity and manufacturing cost reductions. Highlighting scientific advancements for new disease targets to address unmet medical needs with RNA drug products
  • Adopting a pitching style structure, the PolymeRAI$E provides the opportunity to receive direct feedback from a qualified review panel of investors and pharma innovation experts

CXO Forum

  • Tailored for executives from private RNA Biotech companies to engage in discussions on specific commercial routes within the RNA field amongst peers
  • Gaining insights from investor and pharma leaders on case studies of business critical activities such as biotech valuations and how to partner with pharma

Thank You to our Community Partners

Melissa Moore

CSO

Moderna

"A really great place to connect with and network with my peers"

Connect With The Industry Anywhere In The World

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

To begin building your custom sponsorship package today, contact us directly:

LSXSponsors@informaconnectls.com